Michal Karlinski
Overview
Explore the profile of Michal Karlinski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
512
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marto J, Riegler C, Gebert P, Reiff T, Sykora M, Wiacek M, et al.
Eur Stroke J
. 2025 Feb;
:23969873251323488.
PMID: 40017435
Introduction: Evidence regarding the benefit of endovascular therapy (EVT) in patients with acute ischemic stroke (AIS) due to isolated cervical internal carotid artery occlusion (c-ICA-O) is lacking. We assessed the...
2.
Homberg V, Jianu D, Stan A, Strilciuc S, Chelaru V, Karlinski M, et al.
Stroke
. 2025 Feb;
PMID: 39957612
Background: Stroke-induced aphasia significantly impacts communication and quality of life. Despite the standard treatment being speech and language therapy, outcomes vary, highlighting the need for additional therapies. Cerebrolysin, a neuroprotective...
3.
Karlinski M, Kobayashi A, Niewada M, Fryze W, Tomczak A, Brola W, et al.
Neurol Neurochir Pol
. 2023 Dec;
58(1):75-83.
PMID: 38037889
Introduction: The Registry of Stroke Care Quality (RES-Q) is used in Poland for quality monitoring by numerous hospitals participating in the Angels Initiative. Our aim was to assess the degree...
4.
Nowak M, Karlinski M, Sniezynski M, Pozarowszczyk N, Kurkowska-Jastrzebska I, Czlonkowska A
J Stroke Cerebrovasc Dis
. 2023 Sep;
32(11):107341.
PMID: 37757584
Objectives: Our aim was to investigate usefulness of the neutrophil-to-lymphocyte ratio (NLR) for predicting poor response to intravenous rtPA in white Caucasian ischemic stroke patients treated within 4.5 hours from...
5.
Appleton J, Law Z, Woodhouse L, Salman R, Beridze M, Christensen H, et al.
BMJ Neurol Open
. 2023 Jun;
5(1):e000423.
PMID: 37337529
Background: Tranexamic acid reduced haematoma expansion and early death, but did not improve functional outcome in the tranexamic acid for hyperacute spontaneous intracerebral haemorrhage-2 (TICH-2) trial. In a predefined subgroup,...
6.
Pozarowszczyk N, Kurkowska-Jastrzebska I, Sarzynska-Dlugosz I, Nowak M, Karlinski M
Front Neurol
. 2023 Mar;
14:1064642.
PMID: 36937517
Introduction: The Modified Rankin Scale (mRS) is the most common tool to quantify post-stroke disability in everyday practice and by certified raters in clinical trials. However, interobserver variability may affect...
7.
Karlinski M, Kobayashi A, Karaszewski B, Czlonkowska A
Postepy Kardiol Interwencyjnej
. 2022 Aug;
18(1):1-3.
PMID: 35982739
No abstract available.
8.
Farkowski M, Karlinski M, Pytkowski M, de Asmundis C, Lewandowski M, Mugnai G, et al.
Europace
. 2022 Jul;
24(9):1504-1511.
PMID: 35851797
The aim of the study was to systematically review evidence on the effectiveness and safety of oral mexiletine administered in monotherapy or in combination with other antiarrhythmic drugs for recurrent...
9.
Karlinski M, Kozera-Strzelinska D, Sienkiewicz-Jarosz H, Kurkowska-Jastrzebska I, Czlonkowska A
Neurol Neurochir Pol
. 2022 Jan;
56(1):89-95.
PMID: 35089594
Introduction: Early and correct suspicion of an acute cerebrovascular accident (CVA) is necessary to minimise the time to reperfusion treatment. Our aim was to evaluate the reliability of a prehospital...
10.
Law Z, Appleton J, Scutt P, Roberts I, Salman R, England T, et al.
Stroke
. 2021 Dec;
53(4):1141-1148.
PMID: 34847710
Background: Seeking consent rapidly in acute stroke trials is crucial as interventions are time sensitive. We explored the association between consent pathways and time to enrollment in the TICH-2 (Tranexamic...